Ongoing Trials
The Brenden-Colson Center as well as other departments at OHSU are involved in a number of clinical trials for pancreatic cancer early detection and treatment. For more information, please visit ClinicalTrials.gov and search in the Other Terms field by the NCT number of the trial.
| Title | OHSU Lead Investigator | ClinicalTrials.gov number |
|---|---|---|
| Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer | Aaron Grossberg, MD, PhD | NCT04400903 |
| Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabeTes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT) - Early Detection | Brett Sheppard, MD | NCT03460769 |
| A Study of IMMrayTM PanCan-d Test for Early Detection of Pancreatic Cance in High-risk Groups | Brett Sheppard, MD | NCT03693378 |
| Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy | Brett Sheppard, MD | NCT04965311 |
| Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC | Charles Lopez, MD, PhD | NCT03257033 |
| Targeted PARP or MEK/ERK Inhibition in Patients With Pancreatic Cancer (WOO-M IIT) | Charles Lopez, MD, PhD | NCT04005690 |
| NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | Charles Lopez, MD, PhD | NCT04539808 |
| Safety and Efficacy Study of AVB-S6-500 in Patients With Advanced Pancreatic Adenocarcinoma | Charles Lopez, MD, PhD | NCT04983407 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | Christopher W. Ryan, MD | NCT02465060 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | Christopher W. Ryan, MD | NCT02834013 |
| A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment | Emerson Chen, MD | NCT04083235 |
| CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Solid Tumors | Jacqueline Vuky, MD | NCT03425279 |
| Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors | Matthew Taylor, MD Jacqueline Vuky, MD Shivaani Kummar, MD | NCT03485209 |
| Study of ADCT-301 in Patients With Selected Advanced Solid Tumors | Shivaani Kummar, MD | NCT03621982 |
| A Study of SGN-CD228A in Advanced Solid Tumors | Shivaani Kummar, MD | NCT04042480 |
| Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | Shivaani Kummar, MD | NCT04383210 |